Viral Antigens Market is expected to reach US$ 236.80 million by 2027

Coronavirus Antigens Segment to Contribute Largest Share to Market during 2020–2027

According to the latest study on “Viral Antigens Market Forecast to 2027 – COVID-19 Impact and Global Analysis – by Component [Influenza Viral Antigens, Coronavirus Antigens, Zika Virus Antigens, Ebola Virus Antigens, Dengue Virus Antigens, Herpes Simplex Virus (HSV) Antigens, Rotavirus Viral Antigens, Hepatitis A-E Virus Antigens, Measles Virus Antigens, Mumps/Parotitis Virus Antigens, and Others], Technique [ELISA, Immunoassay, Hemagglutination, Radioimmunoassay (RIA), Immunoperoxidase Staining, Immunofluorescence, and Others], and End User [Hospitals, Clinics, Laboratories, Diagnostic Centers, Blood Banks, and Research Institutes] the market was valued at US$ 101.41 million in 2019 and is projected to reach US$236.80 million by 2027; it is expected to grow at a CAGR of 11.0% during 2020–2027. The report highlights trends prevailing in the global viral antigens market, and drivers and restraints pertaining to the market growth.

The growth of the viral antigens market is attributed to the increased acceptance of viral antigens in vaccine development, and advancements in image analysis software and informatics platforms for viral antigen detection. Further, the emerging markets offer lucrative opportunities to the global viral antigens market players. However, the high cost of vaccine development hinders the market growth.

On the basis of component, the viral antigens market is segmented into Influenza Viral Antigens, coronavirus antigens, Zika virus antigens, Ebola virus antigens, Dengue virus antigens, Herpes Simplex Virus (HSV) antigens, rotavirus viral antigens, Hepatitis A-E virus antigens, measles virus antigens, mumps/parotitis virus antigens , and others.

In 2019, the coronavirus antigens segment accounted for the largest share of the market. The growth of the market for this segment is attributed to the rising number of product launches and increasing innovations in corona viral antigens.

Microbix Biosystems, BIO-RAD LABORATORIES INC., Creative Diagnostics, Aalto Bio Reagents Ltd., Advanced Biotechnologies Inc., Prospec-Tany Technogene Ltd., ACROBiosystems., MERIDIAN BIOSCIENCE, INC., Rekom Biotech S.L, and LGC Limited  are among the key players operating in the viral antigens market. These companies focus on partnerships, product launches, and collaborations, among other business strategies, to sustain their market positions. For instance, in May 2020, Bio-Rad Laboratories received the EUA approval from the US FDA for its SARS-CoV-2 Total Ab test, which is a blood-based assay to identify all the antibodies developed by human body in response to the novel coronavirus SARS-CoV-2.

Viral Antigens Market, by Region, 2019 (%)

---

Viral Antigens Market Size and Growth by 2031

Download Free Sample

---

Viral Antigens Market Size and Forecast (2021–2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Component [Influenza Viral Antigens, Coronavirus Antigens, Zika Virus Antigens, Ebola Virus Antigens, Dengue Virus Antigens, Herpes Simplex Virus (HSV) Viral Antigens, Rotavirus Viral Antigens, Hepatitis A-E Virus Antigens, Measles Virus Antigens, Mumps/Parotitis Virus Antigens, and Others], Technique [ELISA, Immunoassay, Hemagglutination, Radioimmunoassay (RIA), Immunoperoxidase Staining, Immunofluorescence, and Others]; End User [Hospitals, Clinics, Laboratories, Diagnostic Centers, Blood Banks, and Research Institutes],  and Geography

The report segments the global Viral Antigens market as follows:

By Component

• Influenza Viral Antigens
• Coronavirus Antigens
• Zika Virus Antigens
• Ebola Virus Antigens
• Dengue Virus Antigens
• Herpes Simplex Virus (HSV) Antigens
• Rotavirus Viral Antigens
• Hepatitis A-E Virus Antigens
• Measles Virus Antigens
• Mumps/Parotitis Virus Antigens
• Others

By Technique

• ELISA
• Immunoassay
• Hemagglutination
• Radioimmunoassay (RIA)
• Immunoperoxidase Staining
• Immunofluorescence
• Others

By End User

• Hospitals
• Clinics
• Laboratories
• Diagnostic Centers
• Blood Banks
• Research Institutes

By Geography

• North America
• US
• Canada
• Mexico
• Europe
• France
• Germany
• Italy
• UK
• Russia
• Asia Pacific
• China
• India
• South Korea
• Japan
• Australia
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE
• South and Central America
• Brazil
• Argentina